A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs
Alexander Karlas(Bayer (Germany)), Marc Lecuit(Inserm), Michaël Meyer(Max Planck Society), Liis Karo-Astover(University of Tartu), Uwe Klemm(Helmholtz Zentrum München), Martin Raftery(University College Cork), Günther Schönrich(Humboldt-Universität zu Berlin), Friderike Weege(Max Planck Institute for Infection Biology), Margus Varjak(MRC University of Glasgow Centre for Virus Research), Franz Bracher(Ludwig-Maximilians-Universität München), Andres Merits(University of Tartu), Thérèse Couderc(Inserm), Nicolas Gangneux(Inserm), Anne Wurzlbauer(Ludwig-Maximilians-Universität München), Stefano Berrè(Inserm), Thomas F. Meyer(Christian-Albrechts-Universität zu Kiel), Peter Braun(Steinbeis Foundation)
Cited by 90
Related Papers
Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication
|Nature|2010|695
A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
|PLoS Pathogens|2008|610
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587